Login / Signup

Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.

Cameron Meyer-MuellerCynthia L NicholsonIngrid C PolcariChristina BoullSheilagh M Maguiness
Published in: Pediatric dermatology (2022)
For infantile hemangiomas (IH) requiring treatment, including those in high-risk locations or in the setting of ulceration, oral propranolol is first-line therapy. Here, we present three cases of infantile hemangioma with worsening ulceration following initiation or escalation of oral propranolol at standard doses.
Keyphrases
  • open label
  • clinical trial
  • stem cells
  • bone marrow
  • cell therapy
  • chemotherapy induced